Browse EyeWorld Weekly ophthalmology news on EyeWorld.org. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ 510k clearance for all-in-one cloud and browser-based software solution ➤ Final Medicare pricing for FSYX Ocular Pressure Adjusting Pump ➤ First patients dosed in Phase 1b/2a study of potential long-acting anti-VEGF therapy ➤ Topline data for Phase 3 clinical trial for treatment of wet AMD ➤ ASCRS news and events ➤ EyeWorld article of the week
➤ FDA acceptance and priority review of NDA for treatment of Stargardt disease type 1 ➤ Ocular development candidate advanced for complement-associated retinal diseases ➤ New integration to expand scleral lens selection and diagnostic flexibility ➤ Clinical results for patients with advanced retinal disease with wearable visual assistive device ➤ Company news ➤ ASCRS news and events ➤ EyeWorld article of the week
➤ FDA clearance of surgical system for canaloplasty followed by trabeculotomy ➤ Latest clinical experience for fully robotic-assisted cataract surgery ➤ Patient enrollment complete in clinical trial evaluating investigational gene therapy for LCA5-associated inherited retinal disease ➤ Enrollment complete in pivotal Phase 3 trials for treatment of DME ➤ Positive FDA pre-IND feedback supporting development strategy for treatment of acute multiple sclerosis relapses ➤ ASCRS news and events ➤ EyeWorld article of the week
➤ FDA approval for treatment of wet AMD ➤ Patient enrollment complete for 510(k) pivotal study for microshunt ➤ Key findings in using PROSE for NK ➤ Successful End-of-Phase 1 Type B meeting for non-atropine eye drop ➤ Digital journal invites original case report submissions ➤ Company news ➤ ASCRS news and events
➤ Launch of preloaded IOL delivery system ➤ First U.S. patient randomized in pivotal study for intermediate to advanced dry AMD ➤ Two new offerings to boost success with presbyopia drop ➤ Company news ➤ ASCRS news and events ➤ EyeWorld article of the week
➤ First patient enrolled in Phase 3 study of cenegermin-bkbj in NAION ➤ New AI-powered digital health platform ➤ FDA Advisory Committee meeting for discussion of low-dose atropine therapy ➤ Selection of lead clinical candidate for gene therapy for Stargardt disease ➤ ASCRS news and events ➤ EyeWorld article of the week
➤ Launch of biosimilar for retinal disease ➤ New partnership to advance perimetry program ➤ Approval of thyroid eye disease treatment ➤ Collaboration to develop adjustable PCIOLs ➤ Progress in treatment for neuropathic corneal pain ➤ Priority review for thyroid eye disease treatment ➤ RMAT designation granted to investigational magnetic human corneal endothelial cell therapy ➤ Complimentary access to video journal ➤ ASCRS news and events ➤ EyeWorld article of the week
➤ First patient dosed in Phase 3 trial for treatment of X-linked retinoschisis ➤ New treatment option for glaucoma ➤ BLA resubmission received by FDA for wet AMD treatment ➤ Company news ➤ Grant opportunity ➤ ASCRS news and events ➤ EyeWorld article of the week
➤ Phase 3 clinical program complete for epithelium-on crosslinking treatment ➤ NDA submitted for oral Stargardt disease therapy ➤ Preclinical data shared for investigational TED therapy ➤ Three new clinical programs to begin for inherited retinal diseases ➤ ASCRS news and events ➤ EyeWorld article of the week
➤ First patient dosed in Phase 3 trial evaluating cenegermin for PCED ➤ First patient dosed in Phase 3 study for Stargardt treatment ➤ First patient randomized into registrational trial for first-in-class dry eye therapy ➤ FDA clears new software for retinal imaging machine ➤ Company news ➤ ASCRS news and events ➤ EyeWorld article of the week
Get the latest ophthalmology news delivered to your inbox every Friday.